Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8614I)
August 13 2019 - 4:20AM
UK Regulatory
TIDMHIK
RNS Number : 8614I
Hikma Pharmaceuticals Plc
13 August 2019
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Khalid Nabilsi
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Khalid Nabilsi
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Disposal of 45,000 Ordinary Shares of 10 pence
transaction each in Hikma Pharmaceuticals PLC.
c) Price(s) and Price(s): GBP19.48
volume(s) Volume(s): 10,000
Price(s): GBP19.50
Volume(s): 5,000
Price(s): GBP19.79
Volume(s): 25,000
Price(s): GBP19.75
Volume(s): 5,000
d) Aggregated information Aggregated volume: 45,000
Price: GBP19.68
Total: GBP885,600
e) Date of the transaction 9 and 12 August 2019
f) Place of the London Stock Exchange (XLON)
transaction
Bassam Kanaan
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Bassam Kanaan
2 Reason for the notification
a) Position/status EVP, Corporate Development and M&A
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Disposal of 84,500 Ordinary Shares of 10 pence
transaction each in Hikma Pharmaceuticals PLC.
c) Price(s) and Price(s): GBP19.47
volume(s) Volume(s): 15,000
Price(s): GBP19.72
Volume(s): 50,000
Price(s): GBP19.79
Volume(s): 5,000
Price(s): GBP19.72
Volume(s): 4,500
Price(s): GBP19.75
Volume(s): 5,000
Price(s): GBP19.70
Volume(s): 5,000
d) Aggregated information Aggregated volume: 84,500
Price: GBP19.68
Total: GBP1,662,990
e) Date of the transaction 9 and 12 August 2019
f) Place of the London Stock Exchange (XLON)
transaction
Peter Speirs, Company Secretary, Responsible for releasing this
announcement
13 August 2019
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHGCGDICBBBGCX
(END) Dow Jones Newswires
August 13, 2019 05:20 ET (09:20 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Apr 2024 to May 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From May 2023 to May 2024